Nektar Therapeutics (NKTR) Work In Process (2011 - 2024)

Nektar Therapeutics' Work In Process history runs 12 years deep, the most recent figure standing at $10.6 million for Q2 2024.

• In Q2 2024, Work In Process changed N/A year-over-year to $10.6 million; the TTM figure through Jun 2024 stood at $10.6 million (changed N/A YoY), while the FY2023 annual figure was $12.9 million, up 19.83% from the prior year.
• Work In Process was $10.6 million for Q2 2024 at Nektar Therapeutics, up from $10.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $12.9 million in Q4 2023 to a low of $10.0 million in Q1 2024.
• Historically, Work In Process has averaged $11.3 million across 3 years, with a median of $10.7 million in 2022.
• Biggest YoY gain for Work In Process was 19.83% in 2023; the steepest drop was 19.83% in 2023.
• A 3-year view of Work In Process shows it stood at $10.7 million in 2022, then grew by 19.83% to $12.9 million in 2023, then fell by 17.78% to $10.6 million in 2024.
• The last three Work In Process figures came in at $10.6 million (Q2 2024), $10.0 million (Q1 2024), and $12.9 million (Q4 2023), per Business Quant data.